Analysts’ Opinions Are Mixed on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), United Therapeutics (UTHR) and Exact Sciences (EXAS)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on GE Healthcare Technologies Inc (GEHC – Research Report), United Therapeutics (UTHR – Research Report) and Exact Sciences (EXAS – Research Report).
GE Healthcare Technologies Inc (GEHC)
In a report released today, Craig Bijou from Bank of America Securities reiterated a Hold rating on GE Healthcare Technologies Inc, with a price target of $86.00. The company’s shares closed last Wednesday at $84.63.
According to TipRanks.com, Bijou is a 3-star analyst with an average return of
GE Healthcare Technologies Inc has an analyst consensus of Moderate Buy, with a price target consensus of $92.29.
See the top stocks recommended by analysts >>
United Therapeutics (UTHR)
Bank of America Securities analyst Jason Gerberry reiterated a Sell rating on United Therapeutics yesterday and set a price target of $280.00. The company’s shares closed last Wednesday at $313.29, close to its 52-week high of $317.46.
According to TipRanks.com, Gerberry is a 2-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for United Therapeutics with a $336.82 average price target.
Exact Sciences (EXAS)
In a report released yesterday, Michael Ryskin from Bank of America Securities reiterated a Buy rating on Exact Sciences, with a price target of $88.00. The company’s shares closed last Wednesday at $45.68, close to its 52-week low of $41.08.
According to TipRanks.com, Ryskin is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Exact Sciences with a $77.91 average price target, a 65.1% upside from current levels. In a report released yesterday, TD Cowen also maintained a Buy rating on the stock with a $80.00 price target.
Read More on GEHC:
